Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Case Report

Reversible Intracranial Cytotoxic Edema Associated with COVID-19: A Case Report

Author(s): Güngör Çakmakci*, Mustafa Çeti̇ner, Gönül Akdağ, Fatma Akkoyun Arikan and Sibel Canbaz Kabay

Volume 20, 2024

Published on: 09 June, 2023

Article ID: e150523216893 Pages: 5

DOI: 10.2174/1573405620666230515090534

open_access

Abstract

Background: It is well-known that COVID-19 causes pneumonia and acute respiratory distress syndrome, as well as pathological neuroradiological imaging findings and various neurological symptoms associated with them. These include a range of neurological diseases, such as acute cerebrovascular diseases, encephalopathy, meningitis, encephalitis, epilepsy, cerebral vein thrombosis, and polyneuropathies. Herein, we report a case of reversible intracranial cytotoxic edema due to COVID-19, who fully recovered clinically and radiologically.

Case Report: A 24-year-old male patient presented with a speech disorder and numbness in his hands and tongue, which developed after flu-like symptoms. An appearance compatible with COVID-19 pneumonia was detected in thorax computed tomography. Delta variant (L452R) was positive in the COVID reverse-transcriptase polymerase chain reaction test (RT-PCR). Cranial radiological imaging revealed intracranial cytotoxic edema, which was thought to be related to COVID-19. Apparent diffusion coefficient (ADC) measurement values in the magnetic resonance imaging (MRI) taken on admission were 228 mm2/sec in the splenium and 151 mm2/sec in the genu. During the follow-up visits of the patient, epileptic seizures developed due to intracranial cytotoxic edema. ADC measurement values in the MRI taken on the 5th day of the patient's symptoms were 232 mm2/sec in the splenium and 153 mm2/sec in the genu. ADC measurement values in the MRI taken on the 15th day were 832 mm2/sec in the splenium and 887 mm2/sec in the genu. He was discharged from the hospital on the 15th day of his complaint with a clinical and radiological complete recovery.

Conclusion: Abnormal neuroimaging findings caused by COVID-19 are quite common. Although not specific to COVID-19, cerebral cytotoxic edema is one of these neuroimaging findings. ADC measurement values are significant for planning follow-up and treatment options. Changes in ADC values in repeated measurements can guide clinicians about the development of suspected cytotoxic lesions. Therefore, clinicians should approach cases of COVID-19 with CNS involvement without extensive systemic involvement with caution.

Keywords: COVID-19, Delta, Reversible, Cytotoxic edema, Seizure, Magnetic resonance imaging.

[1]
Acar T, Acıman DE, Afşar N, et al. The COVID-19 from neurological overview. Turk Noroloji Derg 2020; 26(2): 58-108.
[http://dx.doi.org/10.4274/tnd.2020.73669]
[2]
Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; 87: 18-22.
[http://dx.doi.org/10.1016/j.bbi.2020.03.031] [PMID: 32240762]
[3]
Choi Y, Lee MK. Neuroimaging findings of brain MRI and CT in patients with COVID-19: A systematic review and meta-analysis. Eur J Radiol 2020; 133: 109393.
[http://dx.doi.org/10.1016/j.ejrad.2020.109393] [PMID: 33161199]
[4]
Starkey J, Kobayashi N, Numaguchi Y, Moritani T. Cytotoxic lesions of the corpus callosum that show restricted diffusion: Mechanisms, causes, and manifestations. Radiographics 2017; 37(2): 562-76.
[http://dx.doi.org/10.1148/rg.2017160085] [PMID: 28165876]
[5]
Kandemirli SG, Dogan L, Sarikaya ZT, et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology 2020; 297(1): E232-5.
[http://dx.doi.org/10.1148/radiol.2020201697] [PMID: 32384020]
[6]
Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020; 94: 55-8.
[http://dx.doi.org/10.1016/j.ijid.2020.03.062] [PMID: 32251791]
[7]
Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382(23): 2268-70.
[http://dx.doi.org/10.1056/NEJMc2008597] [PMID: 32294339]
[8]
Li Z, Liu T, Yang N, et al. Neurological manifestations of patients with COVID-19: Potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med 2020; 14(5): 533-41.
[http://dx.doi.org/10.1007/s11684-020-0786-5] [PMID: 32367431]
[9]
Perrin P, Collongues N, Baloglu S, et al. Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol 2021; 28(1): 248-58.
[http://dx.doi.org/10.1111/ene.14491] [PMID: 32853434]
[10]
Garg RK, Paliwal VK, Gupta A. Encephalopathy in patients with COVID-19: A review. J Med Virol 2021; 93(1): 206-22.
[http://dx.doi.org/10.1002/jmv.26207] [PMID: 32558956]
[11]
Gaur P, Dixon L, Jones B, Lyall H, Jan W. COVID-19-associated cytotoxic lesions of the corpus callosum. AJNR Am J Neuroradiol 2020; 41(10): 1905-7.
[http://dx.doi.org/10.3174/ajnr.A6713] [PMID: 32819904]
[12]
Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol 2020; 140(1): 1-6.
[http://dx.doi.org/10.1007/s00401-020-02166-2] [PMID: 32449057]
[13]
Bahranifard B, Mehdizadeh S, Hamidi A, et al. A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19). Neuroradiol J 2022; 35(1): 3-24.
[http://dx.doi.org/10.1177/19714009211029177] [PMID: 34224248]
[14]
Vanderschueren G, Schotsmans K, Maréchal E, Crols R. Mild encephalitis with reversible splenial (MERS) lesion syndrome due to influenza B virus. Pract Neurol 2018; 18(5): 391-2.
[http://dx.doi.org/10.1136/practneurol-2018-001880] [PMID: 29599175]
[15]
Tetsuka S. Reversible lesion in the splenium of the corpus callosum. Brain Behav 2019; 9(11): e01440.
[http://dx.doi.org/10.1002/brb3.1440] [PMID: 31588684]
[16]
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395(10229): 1033-4.
[http://dx.doi.org/10.1016/S0140-6736(20)30628-0] [PMID: 32192578]
[17]
Lopez-Mejia M, Roldan-Valadez E. Comparisons of apparent diffusion coefficient values in penumbra, infarct, and normal brain regions in acute ischemic stroke: Confirmatory data using bootstrap confidence intervals, analysis of variance, and analysis of means. J Stroke Cerebrovasc Dis 2016; 25(3): 515-22.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.10.033] [PMID: 26654670]

© 2024 Bentham Science Publishers | Privacy Policy